Verrica Pharmaceuticals Inc.宣布其开发合作伙伴Torii Pharmaceutical的Ycanth®(to-208)药物在日本获得批准,用于治疗传染性软疣。
Verrica Pharmaceuticals Inc.宣布其开发合作伙伴Torii Pharmaceutical的Ycanth®(to-208)药物在日本获得批准,用于治疗传染性软疣。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.